Dr Ian Niecko, - Psychologist in Juneau, AK

Dr Ian Niecko, is a Psychologist - Counseling based in Juneau, Alaska. Dr Ian Niecko is licensed to practice in Alaska (license number 130024) and his current practice location is 1 Sealaska Plz Ste 303, Juneau, Alaska. He can be reached at his office (for appointments etc.) via phone at (907) 790-7272.

NPI number for Dr Ian Niecko is 1841585163 and his current mailing address is 1 Sealaska Plz Ste 303, Juneau, Alaska. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1841585163.

Contact Information

Dr Ian Niecko,
1 Sealaska Plz Ste 303,
Juneau, AK 99801-1245
(907) 790-7272
Not Available



Healthcare Provider's Profile

Full NameDr Ian Niecko
GenderMale
SpecialityPsychologist - Counseling
Location1 Sealaska Plz Ste 303, Juneau, Alaska
Accepts Medicare AssignmentsDoes not participate in Medicare Program. He may not accept medicare assignment.
  NPI Data:
  • NPI Number: 1841585163
  • Provider Enumeration Date: 06/15/2011
  • Last Update Date: 05/03/2023

Medical Identifiers

Medical identifiers for Dr Ian Niecko such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1841585163NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
103TC1900XPsychologist - Counseling 130024 (Alaska)Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Ian Niecko is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr Ian Niecko,
1 Sealaska Plz Ste 303,
Juneau, AK 99801-1245

Ph: (907) 790-7272
Dr Ian Niecko,
1 Sealaska Plz Ste 303,
Juneau, AK 99801-1245

Ph: (907) 790-7272

News Archive

NOXXON Pharma announces the successful completion of the first phase I trial of Spiegelmer NOX-E36

NOXXON Pharma AG, the biopharmaceutical company focusing on the development of novel drugs based on its unique proprietary Spiegelmer® technology, today announced successful completion of the first phase I trial with its anti-inflammatory Spiegelmer® NOX-E36. This drug candidate will be developed for the treatment of complications of type 2 diabetes, preferentially diabetic nephropathy, but also others.

Link between eating and pain relief - brain stem blocks pain to protect key behaviors

Certain behaviors, such as eating, drinking and urinating, are so crucial to survival that the brains of all vertebrates contain clusters of nerve cells that can suppress pain long enough to allow the animal to eat, drink - or pee - in peace.

Dermatology experts review current screening practice for melanoma in the U.S.

The Future Science Group journal Melanoma Management, today announces the publication of a new perspective article, in which over 50 leaders in the dermatology field critically assess current screening practice for melanoma in the US.

New study shines light on international energy inequality

A new study examines energy inequality for income classes across 86 countries, from highly industrialized to developing ones, revealing extreme disparity in energy footprints, both within nations and globally.

HCV screening of IV drug users new to the prison system could identify thousands of new HCV cases annually

A study published in the March issue of Hepatology, a journal of the American Association for the Study of Liver Diseases, estimates that the prevalence of acute hepatitis C virus (HCV) infection is nearly one percent among newly incarcerated inmates with a history of recent drug use. Findings suggest that systematic screening of intravenous (IV) drug users who are new to the prison system could identify more than 7,000 cases of HCV across the U.S. annually—even among asymptomatic inmates.

Read more News

› Verified 4 days ago


Psychologist in Juneau, AK

Dr. Caroline M. Peters, PSY.D
Psychologist
Medicare: Not Enrolled in Medicare
Practice Location: 3225 Hospital Drive, Ste 202, Juneau, AK 99801
Phone: 907-500-7456    Fax: 907-500-7457
Dr. Destiny Sargeant, PH.D.
Psychologist
Medicare: Not Enrolled in Medicare
Practice Location: 9000 Glacier Hwy, Juneau, AK 99801
Phone: 907-723-9828    
Charles Renick,
Psychologist
Medicare: Not Enrolled in Medicare
Practice Location: 3406 Glacier Hwy, Juneau, AK 99801
Phone: 907-463-3303    
Dr. John Walter Kesselring, PH.D.
Psychologist
Medicare: Not Enrolled in Medicare
Practice Location: 175 S Franklin St, Suite 318, Juneau, AK 99801
Phone: 907-463-4141    Fax: 907-463-4545
Dr. Brendan Joseph Kiernan, PSYD DOCTOR OF PSYCH
Psychologist
Medicare: Not Enrolled in Medicare
Practice Location: 9080 Ninnis Drive, Juneau, AK 99801
Phone: 907-586-4266    Fax: 907-523-4689
Dr. Steven Jozwiak, PH.D., ED.S., M.ED.
Psychologist
Medicare: Not Enrolled in Medicare
Practice Location: 9000 Glacier Hwy, Suite 205, Juneau, AK 99801
Phone: 907-463-3050    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.